Literature DB >> 31637762

Personalized treatment selection using data from crossover designs with carry-over effects.

Chathura Siriwardhana1, K B Kulasekera2, Somnath Datta3.   

Abstract

In this work, we propose a semiparametric method for estimating the optimal treatment for a given patient based on individual covariate information for that patient when data from a crossover design are available. Here, we assume there are carry-over effects for patients switching from one treatment to another. For the K treatment (K ≥ 2) scenario, we show that nonparametric estimation of carry-over effects can have the undesirable property that comparison of treatment means can only be done using independent outcome measurements from different groups of patients rather than using available joint measurements for each patient. To overcome this barrier, we compare probabilities of outcome variable of each treatment dominating outcome variables for all other treatments conditional on patient-specific scores constructed from patient covariates. We suggest single-index models as appropriate models connecting outcome variables to covariates and our empirical investigations show that frequencies of correct treatment assignments are highly accurate. The proposed method is also rather robust against departures from a single-index model structure. We also conduct a real data analysis to show the applicability of the proposed procedure.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  crossover designs; design variables; personalized treatments; precision medicine; single-index models

Mesh:

Substances:

Year:  2019        PMID: 31637762      PMCID: PMC6842056          DOI: 10.1002/sim.8372

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

2.  Design and analysis of crossover trials for absorbing binary endpoints.

Authors:  Martha Nason; Dean Follmann
Journal:  Biometrics       Date:  2010-09       Impact factor: 2.571

3.  Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.

Authors:  Michihiro Takada; Takashi Sozu; Tosiya Sato
Journal:  Pharm Stat       Date:  2015-03-16       Impact factor: 1.894

4.  Bagging and deep learning in optimal individualized treatment rules.

Authors:  Xinlei Mi; Fei Zou; Ruoqing Zhu
Journal:  Biometrics       Date:  2019-03-29       Impact factor: 2.571

5.  Cumulative incidence regression for dynamic treatment regimens.

Authors:  Ling-Wan Chen; Idil Yavuz; Yu Cheng; Abdus S Wahed
Journal:  Biostatistics       Date:  2020-04-01       Impact factor: 5.899

6.  Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

Authors:  J H Anderson; R L Brunelle; P Keohane; V A Koivisto; M E Trautmann; L Vignati; R DiMarchi
Journal:  Arch Intern Med       Date:  1997-06-09

7.  Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies.

Authors:  Haoda Fu; Jin Zhou; Douglas E Faries
Journal:  Stat Med       Date:  2016-02-18       Impact factor: 2.373

8.  A probability based method for selecting the optimal personalized treatment from multiple treatments.

Authors:  Chathura Siriwardhana; Meng Zhao; Somnath Datta; K B Kulasekera
Journal:  Stat Methods Med Res       Date:  2017-11-16       Impact factor: 3.021

Review 9.  Enabling personalized cancer medicine through analysis of gene-expression patterns.

Authors:  Laura J van't Veer; René Bernards
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

10.  Optimization of personalized therapies for anticancer treatment.

Authors:  Alexei Vazquez
Journal:  BMC Syst Biol       Date:  2013-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.